<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00733291</url>
  </required_header>
  <id_info>
    <org_study_id>MS-008</org_study_id>
    <nct_id>NCT00733291</nct_id>
  </id_info>
  <brief_title>Evaluation of Daily Disposable Lenses With Multi-Purpose Solution (MPS)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate daily disposable lenses inserted out of the blister
      package versus daily disposable lenses inserted after a pre-soak in Multi-purpose solution
      FID 107027.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Corneal staining and subjective responses for ocular redness and comfort will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average Corneal Staining Area</measure>
    <time_frame>After 2 hours of wear</time_frame>
    <description>Percentage corneal staining was assessed by the investigator for each of five regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Percentage corneal staining area was recorded in increments of ten, and the percentages of the five regions were averaged together.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Corneal Staining Type</measure>
    <time_frame>After 2 hours of wear</time_frame>
    <description>Total corneal staining type was assessed by the investigator for each of 5 regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Corneal staining type was recorded on a 5-point scale for each region: 0-none; 1-micropunctate; 2-macropunctate; 3-coalesced macropunctate; 4-patch (&gt;/= 1mm). The five regions were summed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ocular Comfort</measure>
    <time_frame>After 2 hours of wear</time_frame>
    <description>Ocular comfort was recorded by the participant on a questionnaire using a 5-point scale. Participant completed the sentence, &quot;Right now my eyes feel...&quot; with one of the following responses: 1-very comfortable; 2-comfortable; 3-neither comfortable nor uncomfortable; 4-uncomfortable; 5-very uncomfortable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ocular Redness</measure>
    <time_frame>After two hours of wear</time_frame>
    <description>Ocular redness was recorded by the participant on a questionnaire using a 5-point scale. Participant completed the sentence, &quot;Right now my eyes look...&quot; with one of the following responses: 1-very white; 2-white; 3-neither white nor red; 4-red; 5-very red.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Nelfilcon A soak / Nelfilcon A no-soak</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nelfilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution, followed by nelfilcon A contact lenses inserted directly from the blister package. Each pair of lenses worn for 2 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nelfilcon A no soak / nelfilcon A soak</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nelfilcon A contact lenses inserted directly from the blister package, followed by nelfilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution. Each pair of lenses worn for 2 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Etafilcon A soak / etafilcon A no soak</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Etafilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution, followed by etafilcon A contact lenses inserted directly from the blister package. Each pair of lenses worn for 2 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Etafilcon A no soak / etafilcon A soak</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Etafilcon A contact lenses inserted directly from the blister package, followed by etafilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution. Each pair of lenses worn for 2 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nelfilcon A contact lens</intervention_name>
    <description>Commercially marketed, single vision, soft contact lens for daily disposable wear</description>
    <arm_group_label>Nelfilcon A soak / Nelfilcon A no-soak</arm_group_label>
    <arm_group_label>Nelfilcon A no soak / nelfilcon A soak</arm_group_label>
    <other_name>Focus Dailies with AquaRelease</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Etafilcon A contact lens</intervention_name>
    <description>Commercially marketed, single vision, soft contact lens for daily disposable wear</description>
    <arm_group_label>Etafilcon A soak / etafilcon A no soak</arm_group_label>
    <arm_group_label>Etafilcon A no soak / etafilcon A soak</arm_group_label>
    <other_name>1-Day ACUVUE Moist</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FID 107027 solution</intervention_name>
    <description>Commercially marketed solution for contact lens disinfection</description>
    <arm_group_label>Nelfilcon A soak / Nelfilcon A no-soak</arm_group_label>
    <arm_group_label>Nelfilcon A no soak / nelfilcon A soak</arm_group_label>
    <arm_group_label>Etafilcon A soak / etafilcon A no soak</arm_group_label>
    <arm_group_label>Etafilcon A no soak / etafilcon A soak</arm_group_label>
    <other_name>Opti-Free RepleniSH Multi-Purpose Disinfecting Solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age or older.

          -  Visual acuity correctable to 20/30 (Snellen) or better in each eye at distance with
             contact lenses.

          -  Successfully wearing hydrogel or silicone hydrogel contact lenses on a daily wear
             basis for at least two weeks prior to study.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  History of hypersensitivity to any components of the multi-purpose solution.

          -  Evidence or history of ocular conditions as prescribed in protocol.

          -  One functional eye or a monofit lens

          -  Any slit-lamp finding score equal to 1 at Visit 1 of each study period.

          -  Significant corneal staining at visit 1 of each study period as prescribed in
             protocol.

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Contact Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2008</study_first_submitted>
  <study_first_submitted_qc>August 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2008</study_first_posted>
  <results_first_submitted>April 10, 2009</results_first_submitted>
  <results_first_submitted_qc>November 16, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 21, 2011</results_first_posted>
  <last_update_submitted>December 21, 2011</last_update_submitted>
  <last_update_submitted_qc>December 21, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 28, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Daily disposable contact lenses</keyword>
  <keyword>Multi-purpose disinfecting solutions</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>64 subjects currently wearing hydrogel or silicone hydrogel lenses on a daily wear schedule for at least two weeks were enrolled between 1/7/08 and 2/1/08 by 4 US optometry sites</recruitment_details>
      <pre_assignment_details>18 hours of no contact lens wear (glasses only) served as the wash out before Period 1. This reporting group includes all enrolled and dispensed participants as treated.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Nelfilcon A Soak / Nelfilcon A no Soak</title>
          <description>Nelfilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution, followed by nelfilcon A contact lenses inserted directly from the blister package. Each pair of lenses worn for 2 hours.</description>
        </group>
        <group group_id="P2">
          <title>Nelfilcon A no Soak / Nelfilcon A Soak</title>
          <description>Nelfilcon A contact lenses inserted directly out of the blister package, followed by nelfilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution. Each pair of lenses worn for 2 hours.</description>
        </group>
        <group group_id="P3">
          <title>Etafilcon A Soak / Etafilcon A no Soak</title>
          <description>Nelfilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution, followed by nelfilcon A contact lenses inserted directly from the blister package. Each pair of lenses worn for 2 hours.</description>
        </group>
        <group group_id="P4">
          <title>Etafilcon A no Soak / Etafilcon Soak</title>
          <description>Etafilcon A contact lenses inserted directly out of the blister package, followed by etafilcon A contact lenses inserted after being soaked overnight in a multi-purpose disinfecting solution. Each pair of lenses worn for 2 hours.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention, 2 Hrs (+/- 30 Min)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="17"/>
                <participants group_id="P4" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="17"/>
                <participants group_id="P4" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout Period, 3 Days (+/-1 Day)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="17"/>
                <participants group_id="P4" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="17"/>
                <participants group_id="P4" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Failed inc criteria Second Intervention</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Intervention, 2 Hrs (+/- 30 Min)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="17"/>
                <participants group_id="P4" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="17"/>
                <participants group_id="P4" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Nelfilcon A Contact Lens</title>
          <description>Commercially marketed, single vision, soft contact lens for daily disposable wear</description>
        </group>
        <group group_id="B2">
          <title>Etafilcon A Contact Lens</title>
          <description>Commercially marketed, single vision, soft contact lens for daily disposable wear</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="29"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="63"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>This reporting group is based on the number of subjects in the evaluable population.</description>
          <units>years</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <description>This reporting group is based on the number of subjects in the evaluable population.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.59" spread="13.90"/>
                    <measurement group_id="B2" value="38.56" spread="12.42"/>
                    <measurement group_id="B3" value="38.11" spread="13.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <description>This reporting group is based on the number of subjects in the evaluable population.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Ocular Comfort</title>
        <description>Ocular comfort was recorded by the participant on a questionnaire using a 5-point scale. Participant completed the sentence, &quot;Right now my eyes feel...&quot; with one of the following responses: 1-very comfortable; 2-comfortable; 3-neither comfortable nor uncomfortable; 4-uncomfortable; 5-very uncomfortable.</description>
        <time_frame>After 2 hours of wear</time_frame>
        <population>This reporting group is based on the number of subjects in the evaluable population for the indicated lens as treated.</population>
        <group_list>
          <group group_id="O1">
            <title>Nelfilcon A / FID 107027</title>
            <description>Nelfilcon A contact lenses soaked overnight in multi-purpose disinfection solution (MPDS) prior to insertion</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A / no Soak</title>
            <description>Nelfilcon A contact lenses inserted directly out of the blister package</description>
          </group>
          <group group_id="O3">
            <title>Etafilcon A / FID 107027</title>
            <description>Etafilcon A contact lenses soaked overnight in multi-purpose disinfection solution (MPDS) prior to insertion</description>
          </group>
          <group group_id="O4">
            <title>Etafilcon A / no Soak</title>
            <description>Etafilcon A contact lenses inserted directly out of the blister package</description>
          </group>
        </group_list>
        <measure>
          <title>Ocular Comfort</title>
          <description>Ocular comfort was recorded by the participant on a questionnaire using a 5-point scale. Participant completed the sentence, &quot;Right now my eyes feel...&quot; with one of the following responses: 1-very comfortable; 2-comfortable; 3-neither comfortable nor uncomfortable; 4-uncomfortable; 5-very uncomfortable.</description>
          <population>This reporting group is based on the number of subjects in the evaluable population for the indicated lens as treated.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
                <count group_id="O3" value="34"/>
                <count group_id="O4" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.86" spread="0.92"/>
                    <measurement group_id="O2" value="1.83" spread="0.80"/>
                    <measurement group_id="O3" value="1.65" spread="0.69"/>
                    <measurement group_id="O4" value="1.88" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Average Corneal Staining Area</title>
        <description>Percentage corneal staining was assessed by the investigator for each of five regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Percentage corneal staining area was recorded in increments of ten, and the percentages of the five regions were averaged together.</description>
        <time_frame>After 2 hours of wear</time_frame>
        <population>This reporting group is based on the number of subjects in the evaluable population for the indicated lens as treated.</population>
        <group_list>
          <group group_id="O1">
            <title>Nelfilcon A / FID 107027</title>
            <description>Nelfilcon A contact lenses soaked overnight in multi-purpose disinfection solution (MPDS) prior to insertion</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A / No Soak</title>
            <description>Nelfilcon A contact lenses inserted directly out of the blister package</description>
          </group>
          <group group_id="O3">
            <title>Etafilcon A / FID 107027</title>
            <description>Etafilcon A contact lenses soaked overnight in multi-purpose disinfection solution (MPDS) prior to insertion</description>
          </group>
          <group group_id="O4">
            <title>Etafilcon A / no Soak</title>
            <description>Etafilcon A contact lenses inserted directly out of the blister package</description>
          </group>
        </group_list>
        <measure>
          <title>Average Corneal Staining Area</title>
          <description>Percentage corneal staining was assessed by the investigator for each of five regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Percentage corneal staining area was recorded in increments of ten, and the percentages of the five regions were averaged together.</description>
          <population>This reporting group is based on the number of subjects in the evaluable population for the indicated lens as treated.</population>
          <units>Percentage area of cornea</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
                <count group_id="O3" value="34"/>
                <count group_id="O4" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" spread="0.39"/>
                    <measurement group_id="O2" value="0.08" spread="0.13"/>
                    <measurement group_id="O3" value="0.34" spread="0.63"/>
                    <measurement group_id="O4" value="0.18" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ocular Redness</title>
        <description>Ocular redness was recorded by the participant on a questionnaire using a 5-point scale. Participant completed the sentence, &quot;Right now my eyes look...&quot; with one of the following responses: 1-very white; 2-white; 3-neither white nor red; 4-red; 5-very red.</description>
        <time_frame>After two hours of wear</time_frame>
        <population>This reporting group is based on the number of subjects in the evaluable population for the indicated lens as treated.</population>
        <group_list>
          <group group_id="O1">
            <title>Nelfilcon A / FID 107027</title>
            <description>Nelfilcon A contact lenses soaked overnight in multi-purpose disinfection solution (MPDS) prior to insertion</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A / no Soak</title>
            <description>Nelfilcon A contact lenses inserted directly out of the blister package</description>
          </group>
          <group group_id="O3">
            <title>Etafilcon A / FID 107027</title>
            <description>Etafilcon A contact lenses soaked overnight in multi-purpose disinfection solution (MPDS) prior to insertion</description>
          </group>
          <group group_id="O4">
            <title>Etafilcon A / no Soak</title>
            <description>Etafilcon A contact lenses inserted directly out of the blister package</description>
          </group>
        </group_list>
        <measure>
          <title>Ocular Redness</title>
          <description>Ocular redness was recorded by the participant on a questionnaire using a 5-point scale. Participant completed the sentence, &quot;Right now my eyes look...&quot; with one of the following responses: 1-very white; 2-white; 3-neither white nor red; 4-red; 5-very red.</description>
          <population>This reporting group is based on the number of subjects in the evaluable population for the indicated lens as treated.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
                <count group_id="O3" value="34"/>
                <count group_id="O4" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.07" spread="0.46"/>
                    <measurement group_id="O2" value="2.10" spread="0.72"/>
                    <measurement group_id="O3" value="2.18" spread="0.76"/>
                    <measurement group_id="O4" value="2.06" spread="0.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Corneal Staining Type</title>
        <description>Total corneal staining type was assessed by the investigator for each of 5 regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Corneal staining type was recorded on a 5-point scale for each region: 0-none; 1-micropunctate; 2-macropunctate; 3-coalesced macropunctate; 4-patch (&gt;/= 1mm). The five regions were summed.</description>
        <time_frame>After 2 hours of wear</time_frame>
        <population>This reporting group is based on the number of subjects in the evaluable population for the indicated lens as treated.</population>
        <group_list>
          <group group_id="O1">
            <title>Nelfilcon A / FID 107027</title>
            <description>Nelfilcon A contact lenses soaked overnight in multi-purpose disinfection solution (MPDS) prior to insertion</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A / no Soak</title>
            <description>Nelfilcon A contact lenses inserted directly out of the blister package</description>
          </group>
          <group group_id="O3">
            <title>Etafilcon A / FID 107027</title>
            <description>Etafilcon A contact lenses soaked overnight in multi-purpose disinfection solution (MPDS) prior to insertion</description>
          </group>
          <group group_id="O4">
            <title>Etafilcon A / no Soak</title>
            <description>Etafilcon A contact lenses inserted directly out of the blister package</description>
          </group>
        </group_list>
        <measure>
          <title>Total Corneal Staining Type</title>
          <description>Total corneal staining type was assessed by the investigator for each of 5 regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Corneal staining type was recorded on a 5-point scale for each region: 0-none; 1-micropunctate; 2-macropunctate; 3-coalesced macropunctate; 4-patch (&gt;/= 1mm). The five regions were summed.</description>
          <population>This reporting group is based on the number of subjects in the evaluable population for the indicated lens as treated.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="29"/>
                <count group_id="O3" value="34"/>
                <count group_id="O4" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.59" spread="1.43"/>
                    <measurement group_id="O2" value="0.79" spread="1.18"/>
                    <measurement group_id="O3" value="1.32" spread="1.80"/>
                    <measurement group_id="O4" value="1.00" spread="1.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>For the duration of the study: 26 days.</time_frame>
      <desc>The safety population is defined as subjects who fulfilled the study entry criteria and had at least one insertion of a daily disposable study lens.</desc>
      <group_list>
        <group group_id="E1">
          <title>Nelfilcon A / FID 107027</title>
          <description>Nelfilcon A contact lenses soaked overnight in multi-purpose disinfection solution (MPDS) prior to insertion</description>
        </group>
        <group group_id="E2">
          <title>Nelfilcon A / no Soak</title>
          <description>Nelfilcon A contact lenses inserted directly out of the blister package</description>
        </group>
        <group group_id="E3">
          <title>Etafilcon A / FID 107027</title>
          <description>Etafilcon A contact lenses soaked overnight in multi-purpose disinfection solution (MPDS) prior to insertion</description>
        </group>
        <group group_id="E4">
          <title>Etafilcon / no Soak</title>
          <description>Etafilcon A contact lenses inserted directly out of the blister package</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI should hold confidential, and not disclose directly or indirectly to any third party other than Contractors, the data arising out of the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alcon Clinical</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>888.451.3937; 817.568.6725</phone>
      <email>medinfo@alconlabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

